BRZENews Brief
By Basis Report Editorial · Updated March 28, 2026
UPDATE March 27: At least five Wall Street analysts cut price targets on Braze, Inc. (BRZE) following Q4 earnings, with UBS delivering the sharpest reduction — slashing its target 35% from $43 to $28 — while Oppenheimer trimmed 25% from $40 to $30. Both firms held their bullish ratings (Buy and Outperform, respectively), but the magnitude of the cuts signals the street has materially reset its view of BRZE's fair value ceiling, even as the underlying business hit its profitability milestones. That reassessment complicates the thesis built around the stock's 19.9% post-earnings surge. A revenue beat and a path to non-GAAP operating profitability drove the initial rally, but analyst consensus now implies roughly 30–35% less upside than it did pre-print. When bulls cut targets by double digits while keeping Buy ratings, it typically reflects a compressed multiple rather than deteriorating fundamentals — the market is paying less per dollar of growth. Watch Q1 FY2027 revenue guidance and net revenue retention rate closely. If NRR stabilizes above 110% and Q1 revenue clears consensus, analysts will have less justification to keep targets anchored this low.

Braze Surges 19.9% on Revenue Beat Despite Profitability Target Push

NEW YORK, March 26 —

Braze Inc. shares jumped 19.9% after the customer engagement platform reported Q4 2025 revenue that exceeded analyst estimates, even as the company missed earnings per share forecasts.

The stock surge came despite mixed quarterly results. Investors focused on Braze's announcement that it targets profitability sometime in 2025. The revenue beat shows continued demand for the company's marketing automation tools. The profitability timeline suggests management confidence in controlling costs and scaling operations efficiently. The EPS miss shows challenges in translating top-line growth into bottom-line results. This pattern affects high-growth software companies transitioning from expansion mode to profit generation.

Wall Street analysts responded with skepticism despite the stock's rally. UBS cut its price target to $28 from $43. Oppenheimer reduced its target to $30 from $40. The downgrades reflect concerns about execution risk in achieving profitability targets while maintaining growth rates in a competitive marketing technology sector. The sharp contrast between the stock's surge and analyst pessimism shows institutional caution about the company's ability to deliver on management promises, particularly given the current earnings shortfall.

Investors should monitor quarterly progress toward the profitability target throughout 2025. Watch for margin expansion and operating leverage improvements. The sustainability of revenue growth rates will be critical. Any deceleration could undermine the profitability timeline and justify the analysts' more conservative price targets. The company's ability to balance growth investments with cost discipline will determine whether this earnings-day rally marks a turning point or a temporary reprieve.

For detailed analysis of Braze's financial metrics and competitive positioning, visit /stock/brze to generate a comprehensive Basis Report.

Basis Report does not hold positions in securities discussed. This is not investment advice.